Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

May 31, 2012

Conditions
Acne Vulgaris
Interventions
DRUG

marketed topical retinoid

once daily application, 4 weeks

DRUG

marketed topical NSAID

once daily application, 4 weeks

DRUG

vehicle gel

once daily application, 4 weeks

DRUG

marketed topical retinoid

once daily application, 4 weeks

Trial Locations (1)

06202

CPCAD - Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT01461655 - Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris | Biotech Hunter | Biotech Hunter